JANX logo

Janux Therapeutics (JANX) Shareholders equity

annual shareholders equity:

$1.02B+$678.43M(+197.02%)
December 31, 2024

Summary

  • As of today (June 17, 2025), JANX annual stockholders equity is $1.02 billion, with the most recent change of +$678.43 million (+197.02%) on December 31, 2024.
  • During the last 3 years, JANX annual shareholders equity has risen by +$656.45 million (+179.20%).
  • JANX annual shareholders equity is now at all-time high.

Performance

JANX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

quarterly shareholders equity:

$1.01B-$10.31M(-1.01%)
March 31, 2025

Summary

  • As of today (June 17, 2025), JANX quarterly stockholders equity is $1.01 billion, with the most recent change of -$10.31 million (-1.01%) on March 31, 2025.
  • Over the past year, JANX quarterly shareholders equity has increased by +$356.71 million (+54.40%).
  • JANX quarterly shareholders equity is now -1.01% below its all-time high of $1.02 billion, reached on December 31, 2024.

Performance

JANX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

JANX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+197.0%+54.4%
3 y3 years+179.2%+184.3%
5 y5 years+10000.0%-

JANX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+218.9%-1.0%+238.1%
5 y5-yearat high+7087.2%-1.0%+6137.0%
alltimeall timeat high+7087.2%-1.0%+6137.0%

JANX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$1.01B(-1.0%)
Dec 2024
$1.02B(+197.0%)
$1.02B(+55.9%)
Sep 2024
-
$656.10M(-0.2%)
Jun 2024
-
$657.68M(+0.3%)
Mar 2024
-
$655.76M(+90.4%)
Dec 2023
$344.35M(+7.4%)
$344.35M(-1.3%)
Sep 2023
-
$348.95M(+16.5%)
Jun 2023
-
$299.47M(-3.8%)
Mar 2023
-
$311.26M(-3.0%)
DateAnnualQuarterly
Dec 2022
$320.74M(-12.4%)
$320.74M(-3.2%)
Sep 2022
-
$331.51M(-3.6%)
Jun 2022
-
$343.81M(-3.4%)
Mar 2022
-
$356.08M(-2.8%)
Dec 2021
$366.33M(-2602.6%)
$366.33M(-2.8%)
Sep 2021
-
$376.75M(-2.1%)
Jun 2021
-
$384.80M(-2394.4%)
Mar 2021
-
-$16.77M(+14.6%)
Dec 2020
-$14.64M(+84.3%)
-$14.64M
Dec 2019
-$7.94M
-

FAQ

  • What is Janux Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Janux Therapeutics?
  • What is Janux Therapeutics annual shareholders equity year-on-year change?
  • What is Janux Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Janux Therapeutics?
  • What is Janux Therapeutics quarterly shareholders equity year-on-year change?

What is Janux Therapeutics annual stockholders equity?

The current annual shareholders equity of JANX is $1.02B

What is the all time high annual shareholders equity for Janux Therapeutics?

Janux Therapeutics all-time high annual stockholders equity is $1.02B

What is Janux Therapeutics annual shareholders equity year-on-year change?

Over the past year, JANX annual stockholders equity has changed by +$678.43M (+197.02%)

What is Janux Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of JANX is $1.01B

What is the all time high quarterly shareholders equity for Janux Therapeutics?

Janux Therapeutics all-time high quarterly stockholders equity is $1.02B

What is Janux Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, JANX quarterly stockholders equity has changed by +$356.71M (+54.40%)
On this page